We are live on ! Find out more
ACER

Acer Therapeutics Inc
ACER

Delisted

ACER was delisted on the 8th of November, 2023.

Back to rankings

13 hedge funds and large institutions have $172K invested in Acer Therapeutics Inc in 2017 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 13 → 13 (0)

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

27% less capital invested

Capital invested by funds: $237K → $172K (-$65K)

67% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 3

Holders
13
Holders Change
–
Holders Change %
0%
% of All Funds
0.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
3
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
TSS
Two Sigma Securities
New York
+$18.3K
2
Bank of New York Mellon
Bank of New York Mellon
New York
+$12.6K
3
BlackRock
BlackRock
New York
+$325

Top Sellers

Rank Fund Capital Flow
1
VKH
Virtu KCG Holdings
New York
-$27.2K
2
ARTA
A.R.T. Advisors
New York
-$21K
3
Vanguard Group
Vanguard Group
Pennsylvania
-$12K
4
FPF
FNY Partners Fund
New York
-$1K
5
UBS Group
UBS Group
Switzerland
-$769

ACER Hedge Fund Activity: Q2 2017 in Review

13 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in Acer Therapeutics Inc (ACER) for Q2 2017, worth a combined $172K — down 27% from $237K a quarter earlier.

Fund positioning in ACER was balanced in Q2 2017: 2 funds opened new positions, 2 closed out, 1 added to existing stakes and 3 trimmed.

The largest buyer was Two Sigma Securities, opening a new position worth an estimated $18.3K. The largest seller was Virtu KCG Holdings, cutting an estimated $27.2K.

  • 13 institutional investors held Acer Therapeutics Inc (ACER) as of Q2 2017, unchanged from Q1 2017.
  • Funds reported $172K of Acer Therapeutics Inc stock for Q2 2017, down 27% quarter-over-quarter.
  • 2 funds opened new Acer Therapeutics Inc positions in Q2 2017 and 2 closed out, a net change of 0 holders.
  • The largest Acer Therapeutics Inc buyer in Q2 2017 was Two Sigma Securities, an estimated $18.3K added.
  • The largest Acer Therapeutics Inc seller in Q2 2017 was Virtu KCG Holdings, an estimated $27.2K sold.

Based on aggregated 13F filings for Q2 2017.